Results 251 to 260 of about 177,036 (313)

Dynamic Evolution of the Tumor Immune Microenvironment in Malignant Tumors and Emerging Therapeutic Paradigms

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Cancer is a complex tumor system consisting of tumor cells, immune effector cells, and all the matrix components. The intricate interactions among cells and molecular signaling pathways in this microenvironment jointly drive tumor growth, invasion, and metastasis, and significantly influence the efficacy of cancer treatment. Meanwhile, the treatment of
Ying Sun   +11 more
wiley   +1 more source

Amperometric NO-recordings of individual OSNs of wild-type, OMP-GFP, or eNOS-deficient mutant mice.

open access: green, 2015
Daniela Brunert   +7 more
openalex   +2 more sources

Tissue Kallikrein as a Mediator in Stroke Outcomes among Patients With Metabolic Syndrome: A Multicenter Study Integrating Big Data and Biomarkers

open access: yesMedComm, Volume 6, Issue 12, December 2025.
Metabolic syndrome is associated with adverse stroke outcomes. KLK1 acts as a mediating factor linking metabolic syndrome and stroke prognosis. KLK1 could be a therapeutic target for stroke patients with metabolic comorbidities. ABSTRACT Metabolic syndrome (MetS) poses a significant risk to the cerebrovascular system, impacting the prognosis of stroke ...
Hang Ruan   +7 more
wiley   +1 more source

Caveolin-1 Is a Central Mediator of Acute Lung Injury in an Animal Model of Sickle Cell Disease. [PDF]

open access: yesPulm Circ
Prohaska CC   +6 more
europepmc   +1 more source

Efeitos da atorvastatina e do polimorfismo T-786C do gene eNOS sobre parâmetros do metabolismo lipídico plasmático Effects of atorvastatin and T-786C polymorphism of eNOS gene on plasma metabolic lipid parameters

open access: green, 2013
Vanessa Helena de Souza Zago   +9 more
openalex   +1 more source

Home - About - Disclaimer - Privacy